Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma.

Shogo ShinoharaShinji TakebayashiKiyomi HamaguchiTetsuhiko MichidaYota TobeTadashi IkenagaMami YasumotoAyami HamamotoToshiyuki ImagumbaiTakamasa MitsuyoshiRyo AshidaTakahiro IwaiShun Okabayashi

Published in: Clinical Medicine Insights. Oncology (2021)

Concurrent chemoradiotherapy/LDC can be safely administered with acceptable toxicity and survival outcome even if the patients with higher age, lower eGFR, and so on.

Keyphrases

locally advanced
rectal cancer
low dose
squamous cell carcinoma
radiation therapy
small cell lung cancer
epidermal growth factor receptor
high dose
tyrosine kinase
oxidative stress
free survival
oxide nanoparticles